Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) CEO Howard W. Robin sold 16,650 shares of Nektar Therapeutics stock in a transaction that occurred on Friday, May 17th. The shares were sold at an average price of $1.75, for a total transaction of $29,137.50. Following the sale, the chief executive officer now directly owns 863,239 shares […]